The KGI 2026 ABCAB Bioprocessing Symposium connects industry professionals and researchers to address current challenges in drug manufacturing. This year’s program focuses on BioPharma 4.0 and Next-Gen Modalities, highlighting digital twins, ML-based modeling, advanced PAT, and automation and smart manufacturing facilities. Hosted by the Amgen Bioprocessing Center Advisory Board (ABCAB) and the MEng program, the event centers on transitioning mRNA, cell, and gene therapies to commercial production. 

Please register by Friday, January 30, 2026. We look forward to seeing you there!